As Dementia Spreads, So Does Geriatrician Shortage
Much attention has been paid to the disproportionate balance of the supply and demand of PCPs. Fewer PCPs also means fewer geriatricians, for which there is already acute demand.
The shortage of primary care physicians around the country affects more than run-of-the-mill patients who endure longer wait times and shorter doctor visits. It also affects a patients who are sick, frail, and may be at the end of their lives—the elderly. That's because the number of geriatricians, PCPs with one to two years of additional training in elder care, is also diminishing.
Caring for an aging patient presents unique challenges for physicians even when the patient is relatively healthy. And when an elderly patient has dementia, their individual needs are more acute, and they need specialized a care beyond what a PCP can give.
"Dementia is not treated in a holistic manner," says Kyle Allen, DO, vice president for clinical integration and medical director for geriatric medicine and the lifelong health division for Newport News, VA–based Riverside Health System made up of seven hospitals, a medical group, and a full continuum of care for aging patients. "Geriatricians who've had the training understand that this is a family illness. This is not just an individual."
The American Geriatrics Society estimates that there will need to be 30,000 geriatricians by 2030, that's when one in five Americans will be eligible for Medicare. There are currently 7,500 geriatricians in the U.S. The gap is so wide, that it casts a pall on the quality of care that could be available in the future.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening